Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Dow
Harvard Business School
Express Scripts
Medtronic

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

INTRON A Drug Profile

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for INTRON A

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Editas Medicine, Inc.Phase 1/Phase 2
AllerganPhase 1/Phase 2
RWTH Aachen UniversityPhase 2

See all INTRON A clinical trials

Recent Litigation for INTRON A

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05
Boston Heart Diagnostics Corporation v. Genelex Corporation2017-08-01

See all INTRON A litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Baylor College of Medicine2018-04-18
Guardant Health, Inc.2017-05-17

See all INTRON A litigation

Pharmacology for INTRON A

Company Disclosures: US Patents for INTRON A

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for INTRON A

These patents were identified by searching patent claims

Supplementary Protection Certificates for INTRON A

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3/2010 Austria   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
10C0004 France   Start Trial PRODUCT NAME: HORMONE FOLLICULO-STIMULANTE COMPRENANT UNE EXTENSION CTP, NOTAMMENT LA CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE IN FRANCE: EU/1/09/609/001 DU 20100125; REGISTRATION NO/DATE AT EEC: EU/1/09/609/001 DU 20100125
122010000006 Germany   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Merck
Baxter
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.